z-logo
open-access-imgOpen Access
Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis
Author(s) -
Marco Bellone,
Lorenzo Pradelli,
Rita Tavarozzi,
Marco Ladetto,
Giuliaepoti,
Emanuele Guardalben,
Daniela Ghislieri
Publication year - 2022
Publication title -
farmeconomia health economics and therapeutic pathways
Language(s) - English
Resource type - Journals
eISSN - 1721-6923
pISSN - 1721-6915
DOI - 10.7175/fe.v23i1.1532
Subject(s) - obinutuzumab , medicine , lymphoma , rituximab

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom